The Food and Drug Administration (FDA) has withdrawn a proposed rule that sought to prohibit tanning bed usage for individuals under 18 years of age. Currently, several states, including California, Delaware, and Illinois, have enacted laws banning minors from using tanning beds, while others permit usage with parental consent. The initial proposal, introduced in 2015, also called for adults over 18 to sign a waiver acknowledging the risks associated with tanning beds, which can emit up to 15 times more ultraviolet (UV) radiation than natural sunlight. The FDA noted that the withdrawal does not diminish the known risks of UV exposure, including skin cancer, which is the most prevalent cancer in the U.S. Concerns raised during the public comment period included the importance of personal choice and the potential impact on small businesses, as well as the vulnerability of young people to the risks posed by tanning beds.
Why It Matters
The FDA’s decision comes amid ongoing concerns about the health risks associated with tanning bed use, particularly for minors. Skin cancer, specifically melanoma, has been shown to have a significantly higher incidence among individuals who use tanning beds before age 20, with a 2025 study revealing a rate of about 5% for tanning bed users compared to 2% for non-users. The American Academy of Dermatology has emphasized that UV radiation is a known carcinogen, similar to substances like tobacco. As tanning beds are classified as class II medical devices, the lack of federal regulations allows states with no age restrictions to bypass the FDA’s warning labels regarding safe usage for minors.
Want More Context? 🔎
Loading PerspectiveSplit analysis...
